Zynerba Pharmaceuticals, Inc. (0M40.L) LSE

1.31

+0.035(+2.76%)

Updated at October 10, 2023 06:54PM

Currency In USD

Valuation

Market Cap22.61M
Enterprise Value-27.7M
P/E Ratio-1.59
PEG Ratio-0.02
Price/Sales Ratio0
Price/Book Ratio1.2
Enterprise/Revenue0
Enterprise/EBITDA-0.57

Fiscal Year

Fiscal YearDecember 31, 2022
Most Recent QuarterJune 30, 2023

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.63
Return On Equity-0.59

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-34.62M
Net Income-34.82M
Diluted EPS-0.82

Balance Sheet

Total Cash35.97M
Total Cash/Share1.19
Total Debt217,879
Total Debt/Equity0.01
Current Ratio5.97
Book Value Per Share1.08

Price History

52-Week Change104.55
52-Week High1.4
52-Week Low0
Moving Average 50 Days1.12
Moving Average 200 Days0.72

Statistics

Average Volume9,810
Shares Outstanding37.56M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A